FDA issued a Warning Letter to Praxair Inc. on 1/7/2015 as a result of this inspection.
FDA investigators audited the Praxair - Tonawanda, NY, United States facility and issued inspectional observations (via FDA 483) on 08 Aug 2014.
Add To Cart
- Category: Human Drugs / Medical Devices & Rad Health
- Inspection end: 08 Aug 2014
- Location: Tonawanda, United States
- FEI: 1000448358